David Clark, PhD

Computer-Aided Drug Design and Information Services

David E. Clark, PhD, is a Research Fellow in Computer-Aided Drug Design (CADD) and Information Services and founding scientific member of Argenta, which was started in 2000 and acquired by CRL in 2014. He began his career working for Proteus Molecular Design, where he was involved in developing software for de novo ligand design and protein-ligand docking. He then spent four years working in the CADD group of Aventis/Rhône-Poulenc Rorer before joining Argenta. David is a graduate of the University of Oxford where he studied chemistry. His post-graduate studies (MSc, PhD) were carried out at the Department of Information Studies at University of Sheffield under the supervision of Professor Peter Willett. In 2003, David was the recipient of the Corwin Hansch award, which is presented annually by the QSAR and Modelling Society. His articles have been published in Drug Discovery Today and his most recent peer-reviewed studies a number of times in BioOrganic and Medicinal Chemistry Letters and in Computational Molecular Science. He is soppy about black Labradors.